'increase synergy' is a correct and usable phrase in written English.
You can use it to describe the outcome of a process or interaction that will bring two or more businesses or entities together to work collaboratively and achieve greater efficiency and success. For example, "We are looking to increase synergy among our departments by merging our accounting and finance teams."
Mission: "To manage, promote and develop the National Network for Research and Education RNIEE) in Mexico and increase synergy among its members".
Its mission and vision are: Mission: "To manage, promote and develop the National Network for Research and Education RNIEE) in Mexico and increase synergy among its members".
CUDI 2009 is under construction; it is a social association without profit that manages the National Network for Education and Research (RENEI-Red Nacional de Educación e Investigación) to promote Mexican development and increase synergy among its members.
We note, however, that the difference between the respective R0 of the two strains is not monotonic below this threshold, and that after the initial increase (synergy), this difference reaches a maximum and then decreases as vectorial capacity rises further (see Figure S3-1 in Supporting Information S3).
This could increase synergy and sustainability in promoting health and preventing disease, and promote physical activity in structural policymaking through different research and networking activities.
Increasing the concentration of monomeric VCA did not increase synergy, suggesting the failure to observe potent synergy is not due to under-saturation of two CA binding sites on the complex.
With Barry Rosensteins (see) Jana Partners, pressuring online brokerage TD Ameritrade to merge with another firm to increase synergies.
(Line in fact invested $45 million into Snow in September at a valuation of $180 million in a bid to increase synergies).
African scientists could increase collaborations in areas of training, education and research which in turn will increase synergies in biomedical and genomic research producing a lower cost for everyone involved.
These failures ought to be a warning about the risks of increasing synergy among major companies.
A more probable scenario is increasing synergy between morphological and molecular aspects of diagnosis.
